Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from FDA

3 Biotech Stock Gems Bursting With Buy Opportunities

The biotech industry is well poised to flourish, buoyed by its commitment to innovation and potential for groundbreaking discoveries. Thus, investing in the shares of three fundamentally solid biotech companies, Foghorn Therapeutics (FHTX), Jazz Pharmaceuticals (JAZZ), and Gilead Sciences (GILD), might be prudent. Continue reading….

StockNews.com

Promising Blood Test Shows Early Alzheimer's Detection Potential

A new study suggests a promising blood test that could diagnose Alzheimer's disease accurately and early, potentially revolutionizing dementia care.

Top News

Top-Notch Pharvaris Eyes Profit-Taking Zone On A Key FDA Decision

Top-notch biotech stock Pharvaris surged Monday after the FDA said it could begin testing a treatment for a swelling disorder in people.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

In Washington state, pharmacists are poised to start prescribing abortion drugs

They're pioneering a new model of care that will allow for one-stop, same-day access to mifepristone — no appointment necessary.

WEKU

Cathie Wood's Flagship ARKK ETF Is Taking On Water Due To Coinbase, Tesla, These Stocks

ARK Innovation, the flagship Cathie Wood ETF, is skidding in 2024 as the S&P 500 hits a record high. Blame Coinbase, Tesla and other big ARKK ETF holdings.

Investors Business Daily

Menthol cigarette ban decision delayed again, sparking public pressure

This informative article discusses the push to ban menthol cigarettes and its potential impact on public health, particularly in black communities.

Top News

SCOTUS hears oral argument in challenge to Chevron deference

The Checks and Balances Letter delivers news and information from Ballotpedia’s Administrative State Project, including pivotal actions at the federal and state levels related to the separation of powers, due process, and the rule of law.

Ballotpedia

Read news from The Economist, FT, and more,
with one subscription

Biden Administration Policy Jeopardizes The System That Gave Us Gene Editing

The White House just released a proposal that would allow federal agencies to rip up patent licensing agreements between universities -- which may receive federal research funds -- and private companies, including biotech firms.

International Business Times

Why people are taking bovine colostrum

Bovine colostrum supplements are taking over, but the evidence for some claims is lacking

Salon

DermaSensor announces AI skincare device that detects three common skin cancers

It's been FDA approved as of yesterday

Governor supports potential reclassification of marijuana as per FDA recommendation

In this informative response, Governor Haley discusses the potential reclassification of marijuana as well as the importance of allowing states to decide i...

Top News

Generic drugs in the US are too cheap to be sustainable, experts say

Non-brand-name drugs are one inexpensive part of the healthcare system but they’re driving some manufacturers out of business

The Guardian - US

"Faux-zempic" driving hospitalizations

Experts warn against the risks of illegitimately obtained Ozempic and Wegovy

Salon

FDA failing children with rare disease

The FDA is holding potential Sanfilippo syndrome therapies to an impossible and inhumane standard

Salon

Get all your
news in one place.

100’s of premium titles.
One news app.

Tom’s Guide

Should you take melatonin gummies to fall asleep fast? Here's what a doctor thinks

Two sleep doctors answer everything you need to know about melatonin gummies, including the side effects, how long they last and how many you should take.

Investors Business Daily

Crispr Wins Its Second Gene-Editing Approval In Another Boost To Vertex Stock

Crispr won its second gene-editing approval on Tuesday — two months ahead of time. But CRSP stock slipped, and VRTX stock rose minimally.

WEKU

What would a second Trump presidency look like for health care?

The former president is reviving campaign promises to undo Obamacare, an idea that fizzled during his first time in office. Based on his record, here's what else he might do in health policy.

Reason

The Newly Unveiled HHS Rationale for Rescheduling Marijuana Underlines Drug Warriors' Dishonesty

The points about marijuana's risks and benefits that the department now concedes were clear long before last August.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

A surgeon general report once cleared the air about smoking. Is it time for one on vaping?

Sixty years ago, the U.S. surgeon general released a report that settled a longstanding public debate about the dangers of cigarettes and led to huge changes in smoking in America

Reason

When Your Heart Becomes a Snitch

Modern medical devices are lifesavers. But they’re vulnerable to hackers and compromise our privacy.

Tom’s Guide

5 smartwatches to watch in 2024: Apple Watch 10, Samsung Galaxy Watch 7 and more

With no shortage of major releases on the docket, 2024 is likely to be an exciting year in the world of smartwatches.

Top News

FDA and NIDA recommend reclassifying marijuana to Schedule 3 substance

Find out about a review by the FDA supporting the reclassification of marijuana as a Schedule 3 substance due to its lower abuse potential and accepted med...

StockNews.com

Will These 3 Pharma Stocks Become Gainers in 2024?

The pharmaceutical sector is anticipated to prosper due to the strong demand for drugs and therapies and the adoption of advanced technologies. So, let’s analyze whether pharmaceutical stocks Kamada (KMDA), Neurocrine Biosciences (NBIX), and Novartis (NVS) are well positioned to capitalize on the industry’s growth prospects.

Top News

FDA deems ResMed's respiratory device recall as most severe

Learn about the recent recall of ResMed's respiratory devices by the US FDA, deemed as the most serious. Find out more about the implications and what acti...

Top News

FDA finds no evidence of suicidal thoughts from diabetes and obesity drugs

The FDA states that popular drugs for diabetes and obesity do not appear to be linked to suicidal thoughts but continues to investigate reports.

1 … 79 80 81 82

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.